Explores synthesis efficiency in synthetic chemistry, indicating a streamlined approach.
A concise diastereoselective synthesis of a key intermediate for the third-generation oral contraceptive etonogestrel is described. The initial first-generation synthesis was conducted on a low-gram scale and afforded 11-methylene-18a-homo-5α-estr-3-one-17β-ol ( 12 ) in 15% overall yield. Key to the route redesign was the simplification of the synthesis by (a) direct introduction of the 9,11 double bond by DDQ oxidation of benzyl-protected 18a-homosteroid, (b) significant improvement of the hydroboration–oxidation step in terms of efficiency, reaction yield, and stereoselectivity, (c) development of a noncryogenic Peterson olefination for installation of a C-11 exocyclic double bond, (d) classical one-pot two-step Birch reduction, and (e) catalytic Oppenauer oxidation. This second-generation process development route was scaled up to afford multigram quantities of the etonogestrel (ENG) precursor 4 with high diastereomeric purity in 10 steps, suitable for further transformation en route to etonogestrel 2 . Moreover, the presented methodology represents, to the best of our knowledge, the shortest synthetic approach to the ENG precursor.
No takes yet. Share an insight, caveat, or question.
Pavlović et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: